|
Mad2 Proteins
|
D12.776.167.313 |
|
|
Catheter-Related Infections
|
D055499 |
[Infections resulting from the use of catheters. Proper aseptic technique, site of catheter placement, material composition, and virulence of the organism are all factors that can influence possible infection.
] |
|
Propyl Gallate
|
D02.455.426.559.389.127.281.200.600 |
|
|
Gallic Acid
|
D02.455.426.559.389.127.281.200 |
|
|
Mediator Complex Subunit 1
|
D12.776.930.617.049 |
|
|
Practice Guidelines as Topic
|
N05.700.350.650 |
|
|
Serotonin Antagonists
|
D27.505.519.625.850.850 |
|
|
Candidiasis, Vulvovaginal
|
C13.351.500.894.906.820.500 |
|
|
Cathepsin C
|
D08.811.277.656.224.130 |
|
|
Zigadenus
|
B01.650.940.800.575.912.250.618.875.625.960 |
|
|
Cystine
|
D12.125.119.369 |
|
|
Tay-Sachs Disease
|
C18.452.648.189.435.825.300.300.500 |
|
|
Plakins
|
D12.776.220.790 |
|
|
Contraceptives, Postcoital, Hormonal
|
D27.505.954.705.360.360.750 |
|
|
Inferior Wall Myocardial Infarction
|
C14.280.647.500.187 |
|
|
Host Adaptation
|
G16.527.200.190 |
|
|
Leishmaniasis, Diffuse Cutaneous
|
C17.800.838.775.560.400.350 |
|
|
Serotonin Receptor Agonists
|
D27.505.519.625.850.800 |
|
|
Yellow Fever
|
C01.920.500.980 |
|
|
Hepatitis A Virus Cellular Receptor 2
|
D12.776.465.798 |
|
